Skip to main content
MEDP
NASDAQ Life Sciences

Medpace Q2 Revenue Beats by $20M, Backlog Conversion Drives 17% Growth

Tom Rudovsky · Reported by Reuters
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$605
Mkt Cap
$15.083B
52W Low
$373
52W High
$628.916
52W Position info
62% above low
Off High info
3.8% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

MEDP sits 62% above its 52-week low of $373.

Summary

Medpace delivered a strong Q2, with revenue of $707.33M beating consensus by nearly $20M on 17% year-over-year growth. Net income rose to $121.36M, and the backlog conversion rate hit 24.1%, signaling efficient execution. New business awards surged 28% to $796M, supporting the raised full-year guidance of $2.805B-$2.885B in revenue and EPS of $17.25-$17.95. The company also repurchased $295M in shares during the quarter, underscoring confidence. This follows a May governance overhaul and a June executive appointment, adding to a narrative of operational momentum. The stock, trading near its 52-week high, may see further upside as the beat and guidance exceed the subdued analyst consensus (average rating: hold).

At the time of this announcement, MEDP was trading at $605.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $15.1B. The 52-week trading range was $373.00 to $628.92. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

MEDP - Latest Insights

MEDP
Oct 22, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $653.96
Real-time Price: $663.49 info
Change: +$9.53 (+1%) info
Market Cap: $18.559B info
MEDP
Oct 21, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $635.00
Real-time Price: $663.49 info
Change: +$28.49 (+4%) info
Market Cap: $18.559B info
MEDP
Oct 21, 2026, 4:15 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $661.00
Real-time Price: $663.49 info
Change: +$2.49 (+0.38%) info
Market Cap: $18.559B info
MEDP
Sep 28, 2026, 7:15 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $615.94
Real-time Price: $663.49 info
Change: +$47.55 (+8%) info
Market Cap: $18.559B info
MEDP
Jul 27, 2026, 4:52 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $589.37
Real-time Price: $663.49 info
Change: +$74.12 (+13%) info
Market Cap: $18.559B info